The Centers for Medicare & Medicaid Services (“CMS”) recently finalized a Medicare payment rule with significant implications for life sciences companies, particularly biotech and pharmaceutical manufacturers….
By: Ropes & Gray LLP
By: Ropes & Gray LLP
